Gene Delivery Using Viral Vectors - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 268

[204] Boviatsis EJ, Park JS, Sena-Esteves M, Kramm CM, Chase M, Efird JT, et al. Long-
term survival of rats harboring brain neoplasms treated with ganciclovir and a her-
pes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res
1994;54:5745-51.
[205] Spector FC, Kern ER, Palmer J, Kaiwar R, Cha TA, Brown P, et al. Evaluation of a live
attenuated recombinant virus RAV 9395 as a herpes simplex virus type 2 vaccine in
guinea pigs. J Infect Dis 1998;177:1143-54.
[206] Koelle DM, Corey L. Recent progress in herpes simplex virus immunobiology and vac-
cine research. Clin Microbiol Rev 2003;16:96-113.
[207] Bernstein DI, Ireland J, Bourne N. Pathogenesis of acyclovir-resistant herpes simplex
type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
Antiviral Res 2000;47:159-69.
[208] Walker J, Leib DA. Protection from primary infection and establishment of latency by
vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host
shutoff (vhs) function. Vaccine 1998;16:1-5.
[209] Aurelian L, Kokuba H, Smith CC. Vaccine potential of a herpes simplex virus type
2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase
(ICP10). Vaccine 1999;17:1951-63.
[210] Palmer JA, Branston RH, Lilley CE, Robinson MJ, Groutsi F, Smith J, et al.
Development and optimization of herpes simplex virus vectors for multiple long-term
gene delivery to the peripheral nervous system. J Virol 2000;74:5604-18.
[211] Braz J, Beaufour C, Coutaux A, Epstein AL, Cesselin F, Hamon M, et al. Therapeutic
efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sen-
sory neurons. J Neurosci 2001;21:7881-8.
[212] Liu X, Brandt CR, Gabelt BT, Bryar PJ, Smith ME, Kaufman PL. Herpes simplex virus
mediated gene transfer to primate ocular tissues. Exp Eye Res 1999;69:385-95.
[213] Spencer B, Agarwala S, Miskulin M, Smith M, Brandt CR. Herpes simplex virus-mediated
gene delivery to the rodent visual system. Invest Ophthalmol Vis Sci 2000;41:1392-401.
[214] Hu Y. Baculovirus as a highly efficient expression vector in insect and mammalian cells.
Acta Pharmacol Sin 2005;26:405-16.
[215] Hunt I. From gene to protein: a review of new and enabling technologies for multi-
parallel protein expression. Protein Expr Purif 2005;40:1-22.
[216] Chuang CK, Sung LY, Hwang SM, Lo WH, Chen HC, Hu YC. Baculovirus as a new
gene delivery vector for stem cell engineering and bone tissue engineering. Gene Ther
2007;14:1417-24.
[217] Paul A, Jardin BA, Kulamarva A, Malhotra M, Cynthia BE. Recombinant baculovirus
as a highly potent vector for gene therapy of human colorectal carcinoma: molecular
cloning, expression, and in vitro characterization. Mol Biotechnol 2010. February 09.
(Epub ahead of print).
[218] Blömer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sus-
tained gene transfer in adult neurons with a lentivirus vector. J Virol 1997;71:6641-9.
[219] Miyoshi H, Takahashi M, Gage FH, Verma IM. Stable and efficient gene trans-
fer into the retina using an HIV-based lentiviral vector. Proc Natl Acad Sci U.S.A.
1997;94:10319-23.
[220] Takahashi M, Miyoshi H, Verme IM, Gage FH. Rescue from Gene photoreceptor
degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene
transfer. J Virol 1999;73:7812-6.
[221] Satsuki K. Construction and characterization of a new influenza virus vector system.
J Juzen Med Soc 1999;108:48-56.